ASKA Pharmaceutical Holdings Co., Ltd.'s total assets for Q3 2024 were ¥91.49B, an increase of 3.65% from the previous quarter. JP:4886 total liabilities were ¥26.30B for the fiscal quarter, a 9.25% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Total Assets
¥ 100.53B
¥ 90.75B
¥ 87.14B
¥ 83.30B
¥ 82.58B
Total Liabilities
¥ 31.34B
¥ 28.82B
¥ 32.61B
¥ 34.41B
¥ 38.07B
Total Equity Gross Minority
¥ 69.19B
¥ 61.93B
¥ 54.53B
¥ 48.89B
¥ 44.51B
Other Metrics
Currency in JPY
ASKA Pharmaceutical Holdings Co., Ltd. Debt to Assets